Waxman-Hatch changes are on the way

The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.

This special Over the Counter episode, brought to you by Total Pharmacy® and Omega Pharmacy Group, dives into how to navigate the business of independent pharmacy and get ahead of key policy changes.

In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.

Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.

Efanesoctocog alfa is a recombinant factor VIII therapy with once-a-week dosing.